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The Zipf distribution is an unambiguous
target that any empirically accurate theory of
the firm must hit. This result, taken together
with those in (21) and (27), place important
limits on models of firm dynamics. That is,
(i) firm growth rates follow a Laplace distri-
bution, (ii) the standard deviation in growth
rates falls with initial firm size according to a
power law, and (iii) large firms pay higher
wages for the same job according to yet
another power law (the so-called wage-size
effect). Because the Zipf distribution obtains
all the way down to the smallest sizes, it
should be possible to derive Kesten-type pro-
cesses and, hence, the Zipf distribution from
a microeconomic model in which individual
agents interact to form productive teams. Al-
though today no analytically tractable models
of this type exist, agent-based computational
results have achieved significant success ac-
cording to these criteria (28).
The Zipf distribution may describe firm
sizes in other countries as well, a conjecture
that can only be tested once individual gov-
ernments make available—and in some cases
gather for the first time—data that purport to
be comprehensive.
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Stem Cells in the Developing
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Many central nervous system regions at all stages of life contain neural stem
cells (NSCs). We explored how these disparate NSC pools might emerge. A
traceable clone of human NSCs was implanted intraventricularly to allow its
integration into cerebral germinal zones of Old World monkey fetuses. The
NSCs distributed into two subpopulations: One contributed to corticogenesis
by migrating along radial glia to temporally appropriate layers of the cortical
plate and differentiating into lamina-appropriate neurons or glia; the other
remained undifferentiated and contributed to a secondary germinal zone (the
subventricular zone) with occasional members interspersed throughout brain
parenchyma. An early neurogenetic program allocates the progeny of NSCs
either immediately for organogenesis or to undifferentiated pools for later use
in the “postdevelopmental” brain.
As cells with stemlike qualities have come to
be identified within a widening range of or-
gans [e.g., (1, 2)], new questions have arisen
about their relevance to normal development.
The central nervous system (CNS) may serve
as a bellwether for insights in this field. NSCs
have been identified in the mammalian CNS,
including humans (3–9), at stages from fetus
to adult in a surprisingly wide range of re-
gions (10–13). NSCs, defined as self-renew-
ing, propagatable primordial cells each with
the capacity to give rise to differentiated
progeny within all neural lineages in all re-
gions of the neuraxis, are posited to exist in
the embryonic and fetal ventricular germinal
zone (VZ) where they participate in CNS
organogenesis (5, 14, 15). Cells equally
“stemlike” in their potential have been iden-
tified at later stages (including old age) from
a variety of regions: subventricular (SVZ)
(13–17) and ependymal (18) zones of the
forebrain, subgranular zone of the hippocam-
pus (6–10, 19), retina (20) and optic nerve
(10, 11), cerebellum (12), spinal cord (21),
and even cortical parenchyma (10, 15, 22).
How might these observations be reconciled?
Are such stemlike pools, particularly those
isolated from various parenchymal regions at
“postdevelopmental” periods, of physiologi-
cal relevance or artifacts of experimental ma-
nipulation (10, 11)? Do these populations
represent the same lineage or unique pools
(17)? Of what relevance are these cells to
normal human CNS development and repair?
We hypothesized that multiple stem cell
pools, descendants of a common NSC,
emerge during early cerebrogenesis as cells
are used in organogenesis and concurrently
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also set aside to establish a reservoir for
subsequent use in homeostasis and repair.
This could represent a developmental strate-
gy in which plasticity is programmed into the
CNS at the single-cell level from early stages
of embryogenesis.
We sought to determine how progeny of a
single traceable clone of NSCs get segregated
during development by using a system that
might also lend insight into human develop-
ment. We grafted a clone of NSCs of human
derivation (5, 23) into the developing brains
of fetal bonnet monkeys (Macaca radiata),
an Old World species (Web note 1) (24). We
asked what the fate would be of human cells
transplanted at a time when neocortical cell
genesis, migration, and differentiation are in-
tensive (25–27). The primate neocortex, at
the appropriate developmental stage, allows a
distinction between layers of active neuron
birth and layers where neurogenesis has been
completed and glial cells are instead acquired
(27) (Web note 2) (24) (Fig. 1, schematics I
and II). One can discern experimentally the
responses to local developmental cues simply
by assaying the spatial segregation and pat-
terns of differentiation of NSCs of a single
clone in a given animal’s brain after a single
transplantation procedure. [A summary of
simian cortical development is provided in an
expanded legend to Fig. 1 in Web note 2
(24)]. Under transabdominal ultrasonic guid-
ance, bonnet monkey fetuses at 12 to 13
weeks gestation received a single in utero
injection of ;2 3 107 clonally related undif-
ferentiated NSCs [prelabeled with the nuclear
marker 5-bromo-29-deoxyuridine (BrdU)]
into the left lateral cerebral ventricle, allow-
ing the cells access to the VZ from which the
cerebral cortex is derived (23). [At 12 to 13
weeks, VZ cells normally cease giving rise to
the neurons in layers IV to VI and begin
contributing to neurogenesis in layers II and
III (27) (Fig. 1, schematic I).] Pregnancy was
allowed to continue to the completion of most
cortical neurogenesis at ;16 to 17 weeks
gestation (Fig. 1, schematic II), when the
fetuses were delivered by Cesarean section
and their brains were processed for histolog-
ical analysis (28) (Fig. 2). Distribution of
donor human NSCs (hNSCs) in the monkey
brains was monitored by immunocytochemi-
cal staining for the BrdU marker (Figs. 1 and
3) (28). To provide further independent con-
firmation of the cells’ origin, we used, in
parallel, antibodies against additional donor-
specific markers, including the human-spe-
cific nuclear mitotic antigen (NuMA) as well
as other species-specific tags (28). The phe-
notypes of these cells were characterized by
immunocytochemistry (28) (Fig. 3).
Unilaterally injected hNSCs distributed
themselves throughout both cerebral hemi-
spheres symmetrically and at most levels of
the neuraxis, settling in diverse widespread
regions of the telencephalon, principally at
the frontal and frontoparietal levels (Fig. 3).
Although the individual hNSCs were clonally
related, they appeared to segregate into two
subpopulations (Fig. 3), as follows.
Cells in subpopulation 1 (red stars in Fig.
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Fig. 1. Clonal hNSCs mi-
grate from ventricular
germinal zone (VZ) into
developing neocortex. On
the left are schematics of
the developing monkey
neopallium at the time of
transplantation (I) [12 to
13 weeks postcoitum
(pc)] and at the time of
death (II) (16 to 17 weeks
pc). See (27) and Web
note 2 for brief descrip-
tion of primate neocorti-
cal development. Trans-
plantation is described in




tion relative to the sche-
matic is indicated by
brackets.) (A) Injected
into the left lateral ventri-
cle and having integrated
throughout the VZ, the
hNSC-derived cells (d),
identified by their BrdU
immunoreactivity (black
nuclei), migrated along
the monkey’s radial glial
processes [visualized with
an antibody to vimentin
(brown)] through the
neopallial wall to reach
their temporally appropriate destination in the nascent superficial layers II and III (A), where they
detached from the radial glia and took up residence as neurons (see Fig. 3 for closeups and
characterization). Arrows indicate climbing cells (both donor- and host-derived) positioned along
the processes of the vimentin-positive host radial glia. Some cells (inset) are pictured still attached
to these fibers and in the process of migration. The photomicrographs in (B) and (C) show examples
of immature, donor hNSC-derived (BrdU-positive black nuclei, d) astrocytes (brown vimentin-
positive immunostain) intermixed with host-derived astrocytes in deeper cortical lamina, having
differentiated as expected for that site and time. Abbreviations: MZ, marginal zone; CP, cortical
plate; SP, subplate; WM, white matter; II to VI, cortical layers. Scale bar, 35 mm.
Fig. 2. Evaluation of engrafted
monkey brains at the conclusion
of neocortical development.
Brains were retrieved as de-
scribed in (23) and analyzed in
three anterior-posterior seg-
ments (I to III), as illustrated. For
histological methods, see (28).
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3) appeared to traverse great distances (;1.6
cm or ;1600 times a migrating cell body
diameter) from the periventricular germinal
zones along host radial glial processes (Fig.
1A) to terminate at developmentally and tem-
porally appropriate cortical laminae and dif-
ferentiate into several neuronal (Fig. 3, A to
D) and glial (Fig. 3, E to G) cell types. Those
hNSCs that migrated to the superficial neu-
rogenic cortical layers II and III (Fig. 1A,
schematic II) appropriately became neurons
(Fig. 3A, arrow), identified by dual immuno-
reactivity to antibodies to NeuN, calbindin,
and neurofilament (Fig. 3, B to D, arrows),
intermixed with the monkey’s own neurons
(arrowheads). The majority of the hNSC-
derived neurons were found in cortical layers
II and III [which, at the time of transplant,
profited from an intensive supply of newly
formed neurons (27, 29)]. Those hNSC-de-
rived cells that stopped and integrated within
the deeper cortical layers IV to VI differen-
tiated appropriately into glial cells (Fig. 1, B
and C, schematic II), identified by immuno-
reactivity to glial fibrillary acidic protein
(GFAP) (for astrocytes) or to 29,39-cyclic
nucleotide 39-phosphohydrolase (CNPase)
(for oligodendrocytes) (Fig. 3, E to G). [Glial
cells of donor origin were also appropriately
observed in the marginal zone (MZ, layer I)
(Fig. 1, schematic II) and in subcortical re-
gions. Some donor cells contributed also to
the radial glial cell population.]
Cells in subpopulation 2 (blue dots in Fig.
3) were small, undifferentiated BrdU-positive
cells lacking neuronal processes and were
dispersed throughout the SVZ as single cells
or small clusters intermingled with the ger-
minal cells of the host (Fig. 3, H and I). When
double-stained for cell type–specific anti-
gens, these cells expressed vimentin (an im-
mature progenitor/stem cell marker) (Fig. 3I
and inset) but were negative for all other
markers of differentiation. The majority of
such undifferentiated hNSC-derived cells re-
mained within the SVZ [none in the ependy-
ma (18)]. The SVZ has been implicated in
postnatal and adult homeostatic mechanisms
Fig. 3. Segregation of the
fates of hNSCs and their
progeny into two subpopula-
tions in the brains of devel-
oping Old World monkeys.
Schematics (left) and pho-
tomicrographs (right) illus-
trating the distribution and
properties of clonal hNSC-
derived cells. [Each coronal
section in the schematic (I to
III) corresponds to a coronal
level (I to III) in Fig. 2.]
hNSCs [labeled with BrdU
and implanted as per (23)]
dispersed throughout and in-
tegrated into the VZ. From
there, clonally related hNSC-
derived cells pursued one of
two fates, as shown by im-
munocytochemical analysis
(A to I) (28). Those donor
cells that migrated outward
from the VZ along radial gli-
al fibers (as per Fig. 1) into
the developing neocortex
constituted one pool or sub-
population. The differentiat-
ed phenotypes of cells in this
subpopulation 1 (red stars in
the schematic) (particularly
in layers II and III) are pic-
tured in panels (A) to (G). (A)
An hNSC-derived BrdU-posi-
tive cell (black nucleus, ar-
row)—likely a neuron ac-
cording to its size, morphol-
ogy, large nucleus, and loca-
tion—is visualized (under
Nomarski optics) intermin-
gled with the monkey’s own
similar neurons (arrow-
heads) in neocortical layers II and III. The neuronal identity of such
donor-derived cells is confirmed by immunocytochemical analysis in (B)
to (D). (B, C, and E to G) High-power photomicrographs of human
donor-derived cells integrated into the monkey cortex double-stained
with antibodies against BrdU and cell type–specific markers: (B) NeuN
and (C) calbindin for neurons (arrows, donor-derived cells; arrowheads,
host-derived cells). (E) CNPase for oligodendroglia (arrow, BrdU-positive
black nucleus in CNPase-positive brown cell; arrowhead indicates long
process emanating from the soma). (F and G) GFAP for astroglia [anti-
body to Brd U revealed via fluorescein in (F); antibody to GFAP revealed
via Texas Red in (G)]. The human origin of the cortical neurons is further
independently confirmed in (D) where the human-specific nuclear marker
NuMA (black nucleus) is colocalized in the same cell with neurofilament
(NF) immunoreactivity (brown). Progeny from this same hNSC clone
were also allocated to a second cellular pool—subpopulation 2 [blue dots
in the schematic and pictured in (H) and (I) (arrows)]—that remained
mainly confined to the SVZ and stained only for an immature neural
marker [vimentin (brown) colocalized with BrdU (black nucleus) better
visualized in inset (arrows); arrowhead indicates host vimentin-positive
cell]. Some members of subpopulation 2 were identified within the devel-
oping neocortex (blue dots) intermixed with differentiated cells. (F) and (G)
use immunofluorescence; the other immunostains use a DAB-based color
reaction. The photomicrographs were taken from different animals as rep-
resentative of all animals. ve, lateral cerebral ventricle; arrow, BrdU-positive
donor-derived cell; arrowhead, BrdU-negative, host-derived cell except in (E).
Scale bars, 30 mm [(A) to (C)]; 20 mm [(D) to (I)].
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(16, 17, 30, 31) and as an ongoing source of
cortical neurons after overt cortical develop-
ment has ceased (32–34). A small number of
subpopulation 2 cells, however, were present
within the striatum and cortex, intermixed
with the differentiated cells (Fig. 3). These
cells may provide a local resident pool for
self-repair and plasticity and may represent
the stemlike cells extracted by several inves-
tigators (10, 13, 15, 22, 35). [This observa-
tion favors the interpretation that such report-
ed cells are not simply the result of dediffer-
entiation of committed progenitors, an arti-
fact of experimental manipulation, as has
occasionally been speculated (10, 11)].
Our data provide a plausible dynamic for
how multiple, disparate stem cell populations
are generated as part of a single strategy of NSC
allocation. The clonal progeny of a given NSC
segregate to yield some differentiated cells for
organogenesis (e.g., subpopulation 1) and other
cells (e.g., subpopulation 2) for deposition in
secondary germinal zones (e.g., the SVZ) as a
reservoir. The NSCs that have been isolated
from adults are likely descendants of the same
NSCs that contributed to embryonic and fetal
CNS development and thus do not represent a
unique pool. In this view, ongoing lifelong
self-repair and plasticity are a fundamental de-
velopmental program set in place during early
stages of brain organogenesis. Grafted hNSCs
appear to become integrated into the morpho-
genetic program of the developing primate host
brain (Figs. 1 and 3) (36). Although it was not
technically possible in these monkeys to quan-
tify rigorously the percentage of grafted cells
that survived, the histological images show that
a large number of donor-derived cells were
present bilaterally in all recipients (37, 38). That
hNSCs can migrate through the large expanse
of the primate cerebrum, not merely through the
much smaller rodent brain (5–7), suggests that
migration may be a fundamental stem cell prop-
erty limited only by available terrain (large or
small). In rodents, NSCs have been shown to be
well-suited for transplant-based approaches to
gene therapy and/or cell replacement in diseas-
es characterized by extensive or global abnor-
malities (39). Our results suggest that this ap-
proach may similarly be feasible in large pri-
mates and possibly humans.
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Genetic self-incompatibility in Brassica is determined by alleles of the trans-
membrane serine-threonine kinase SRK, which functions in the stigma epider-
mis, and of the cysteine-rich peptide SCR, which functions in pollen. Using
tagged versions of SRK and SCR as well as endogenous stigma and pollen
proteins, we show that SCR binds the SRK ectodomain and that this binding is
allele specific. Thus, SRK and SCR function as a receptor-ligand pair in the
recognition of self pollen. Specificity in the self-incompatibility response de-
rives from allele-specific formation of SRK-SCR complexes at the pollen-stigma
interface.
In self-incompatible Brassica plants, self-
pollinations and crosses between genetically
related individuals are nonproductive because
self-related pollen grains are inhibited upon
contact with the epidermal cells of the stigma,
a structure that caps the female reproductive
organ. Specificity in this self-incompatibility
(SI) response is determined by haplotypes of
the polymorphic S locus. The self-recognition
molecules encoded by this locus include the
single-pass transmembrane receptor–like
serine-threonine kinase SRK, which func-
tions in the stigma epidermis (1–3) and be-
comes phosphorylated upon self-pollination
(4), and the cysteine-rich peptide SCR, which
functions in pollen (5, 6). These two mole-
cules are highly polymorphic, with allelic
forms of SRK and SCR exhibiting 10 to 30%
and .60% divergence, respectively (1, 5–8).
Views of SRK as a ligand-activated receptor
kinase and SCR as its ligand are consistent
with the predicted molecular properties of
these molecules and the rapidity of the SI
response (1, 9). The SCR peptide is localized
on the surface of pollen grains (10). During
self-pollination, SCR is predicted to bind the
receptor domain of its cognate SRK, thereby
triggering an intracellular phosphorylation
cascade that leads to inhibition of pollen hy-
dration and germination. Specificity in the SI
response is thought to result from haplotype-
specific activation of SRK by SCR. Here, we
describe experiments that demonstrate a
physical and haplotype-specific interaction
between SCR and the ectodomain of SRK.
To investigate the SRK-SCR interaction, we
generated tagged versions of the two proteins.
Recombinant eSRK6, consisting of the ectodo-
main of SRK6 (from the S6 haplotype) and
carrying a COOH-terminal FLAG epitope tag,
was expressed as a soluble secreted glycopro-
tein in Nicotiana benthamiana leaves using the
potato virus X expression system (11). eSRK6
protein migrated as two molecular mass forms
of ;63 and 70 kD on SDS–polyacrylamide gel
electrophoresis (SDS-PAGE), which presum-
ably reflect differential glycosylation of
eSRK6-FLAG in Nicotiana leaves. SCR6 and
SCR13 (the SCRs of the S6 and S13 haplotypes,
respectively) were expressed in bacteria as se-
creted periplasmic proteins carrying a COOH-
terminal myc-His6 tag (11). They exhibited ex-
pected masses of ;8 and 9 kD, respectively,
but they migrated as doublets, possibly due to
inefficient cleavage of the periplasmic signal
peptide in bacteria.
Recombinant SCR-myc-His6 was shown
to be biologically active in pollination bioas-
says (12). Pretreatment of stigmas with puri-
fied “self ” SCR protein (i.e., S6S6 stigmas
with SCR6-myc-His6 or S13S13 stigmas with
SCR13-myc-His6) mixed with pollen-coat
protein carrier (12) caused these stigmas to
inhibit the germination of normally compati-
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stigmas (A) and S2S2
stigmas (B) were treat-
ed with SCR6-myc-His6
and pollinated with S13
pollen (12). Addition of
“self ” SCR6-myc-His6
triggers inhibition of
normally compatible S13 pollen on S6S6 but not on S2S2 stigmas.
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